Showing results (81-90 of 483) with videos related to
Sort By:
Pageof 49
Journal of Psychosomatic Research|January 4, 2011
Instruments to measure sexual dysfunction in community and psychiatric populationsSakina J Rizvi, Niette W Yeung, Sidney H KennedyCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 3, 2002
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxineJ D Vanderkooy, Sidney H Kennedy, R Michael BagbyJournal of Consulting and Clinical Psychology|March 21, 2012
Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorderKate L Harkness, R Michael Bagby, Sidney H KennedyPsychiatry Research|February 21, 2017
Is tetraethyl lead poison affecting contemporary indigenous suicides in Ontario, Canada?Trehani Mary Fonseka, Gerald P McKinley, Sidney H KennedyHuman Psychopharmacology|March 28, 2013
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depressionDan J Stein, Francoise Picarel-Blanchot, Sidney H KennedyCurrent Medical Research and Opinion|February 13, 2009
Escitalopram in the treatment of major depressive disorder: a meta-analysisSidney H Kennedy, Henning F Andersen, Michael E ThaseJournal of Psychiatric Research|May 27, 2003
Early age at onset as a risk factor for poor outcome of bipolar disorderTasha D Cate Carter, Emanuela Mundo, Sagar V Parikh, et al.Psychopharmacology Bulletin|March 28, 2020
Psychiatric Prescribing Patterns for Depression Treatment in an Outpatient Depression ClinicRoberta E Wilson, Sarah J Choi, Sagar V Parikh, et al.Focus (American Psychiatric Publishing)|November 9, 2020
Next-Step Treatment Considerations for Patients With Treatment-Resistant Depression That Responds to Low-Dose Intravenous KetamineWilliam V Bobo, Patricio Riva-Posse, Fernando S Goes, et al.The Journal of Clinical Psychiatry|June 20, 2020
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 ReportRudolf Uher, Benicio N Frey, Lena C Quilty, et al.Pageof 49